Vitamin D Insufficiency and Hyperparathyroidism in Children with Chronic Kidney Disease

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2008 Jun 26

PMID 18575896

Citations 35

Authors

Shina Menon

Rudolph P Valentini

Guillermo Hidalgo

Lena Peschansky

Tej K Mattoo

Affiliations

Soon will be listed here.

Abstract

Chronic kidney disease (CKD) is associated with altered calcium-phosphate homeostasis and hyperparathyroidism due to decreased activity of 1alpha-hydroxylase and impaired activation of 25-hydroxyvitamin D3 [25(OH)D3]. In some patients these problems start earlier because of vitamin D deficiency. A retrospective review of patients followed in the chronic renal insufficiency clinic at Children's Hospital of Michigan assessed the prevalence of vitamin D deficiency in CKD stages 2-4 and evaluated the effect of treatment with ergocalciferol on serum parathormone (PTH). Blood levels of 1,25 dihydroxyvitamin D3, 25(OH)D3, and parathormone (PTH) were examined in 57 children (40 boys; mean age 10.6 years). Of 57 subjects, 44 (77.2%) had 25(OH)D3 levels < or =30 ng/ml, with overall mean of 26.4 +/- 14.3 ng/ml. PTH for patients with 25(OH)D3 levels >30 ng/ml was 67.84 +/- 29.09 ng/ml and in the remaining patients was elevated, at 120.36 +/- 86.42 ng/ml (p = 0.05). Following ergocalciferol treatment (22), PTH decreased from 122.13 +/- 82.94 ng/ml to 80.14 +/- 59.24 ng/ml (p < 0.001) over a period of 3 months. We conclude that vitamin D deficiency is common in children with CKD stages 2-4 and is associated with hyperparathyroidism in the presence of normal 1,25 dihydroxyvitamin D3. Its occurrence before significant renal impairment is noteworthy. Early diagnosis and appropriate treatment is emphasized.

Citing Articles

Cardiometabolic factors and vitamin D deficiency in pediatric patients with chronic kidney disease.

Parra-Ortega I, Zurita-Cruz J, Villasis-Keever M, Klunder-Klunder M, Vilchis-Gil J, Zepeda-Martinez C Front Nutr. 2024; 11:1480424.

PMID: 39439522 PMC: 11493722. DOI: 10.3389/fnut.2024.1480424.

Vitamin D Deficiency in Chronic Childhood Disorders: Importance of Screening and Prevention.

Joshi M, Uday S Nutrients. 2023; 15(12).

PMID: 37375708 PMC: 10302516. DOI: 10.3390/nu15122805.

Effect of vitamin and mineral supplementation on nutritional status in children with chronic kidney disease: Protocol for a systematic review and meta-analysis.

Mutsuddi A, Das J, Tashrik S, Ara R, Hawlader M Medicine (Baltimore). 2022; 101(43):e31518.

PMID: 36316853 PMC: 9622657. DOI: 10.1097/MD.0000000000031518.

The clinical relevance of native vitamin D in pediatric kidney disease.

Banerjee S, Sengupta J, Basu S Pediatr Nephrol. 2022; 38(4):945-955.

PMID: 35930049 DOI: 10.1007/s00467-022-05698-9.

Intermittent cholecalciferol supplementation in children and teenagers followed in pediatric nephrology: data from a prospective single-center single-arm open trial.

Aurelle M, Basmaison O, Ranchin B, Kassai-Koupai B, Sellier-Leclerc A, Bertholet-Thomas A Eur J Pediatr. 2019; 179(4):661-669.

PMID: 31873802 DOI: 10.1007/s00431-019-03553-y.

References

Gordon C, DePeter K, Feldman H, Grace E, Emans S . Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med. 2004; 158(6):531-7. DOI: 10.1001/archpedi.158.6.531. View

Chadha V, Warady B . Epidemiology of pediatric chronic kidney disease. Adv Chronic Kidney Dis. 2005; 12(4):343-52. DOI: 10.1053/j.ackd.2005.07.013. View

Thomas M, Lloyd-Jones D, Thadhani R, Shaw A, Deraska D, Kitch B . Hypovitaminosis D in medical inpatients. N Engl J Med. 1998; 338(12):777-83. DOI: 10.1056/NEJM199803193381201. View

Al-Aly Z, Qazi R, Gonzalez E, Zeringue A, Martin K . Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis. 2007; 50(1):59-68. DOI: 10.1053/j.ajkd.2007.04.010. View

Cozzolino M, Gallieni M, Brancaccio D, Arcidiacono T, Bianchi G, Vezzoli G . Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure. J Nephrol. 2006; 19(5):566-77. View

Zisman A, Hristova M, Ho L, Sprague S . Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol. 2007; 27(1):36-43. DOI: 10.1159/000098561. View

LaClair R, Hellman R, Karp S, Kraus M, Ofner S, Li Q . Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005; 45(6):1026-33. DOI: 10.1053/j.ajkd.2005.02.029. View

Birge S, Haddad J . 25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest. 1975; 56(5):1100-7. PMC: 301971. DOI: 10.1172/JCI108184. View

Halloran B, Schaefer P, Lifschitz M, Levens M, GOLDSMITH R . Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3. J Clin Endocrinol Metab. 1984; 59(6):1063-9. DOI: 10.1210/jcem-59-6-1063. View

10.

Holick M . Vitamin D and the kidney. Kidney Int. 1987; 32(6):912-29. DOI: 10.1038/ki.1987.295. View

11.

CHAPUY M, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S . Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997; 7(5):439-43. DOI: 10.1007/s001980050030. View

12.

Stefanidis C, Klaus G . Growth of prepubertal children on dialysis. Pediatr Nephrol. 2007; 22(9):1251-9. PMC: 6904393. DOI: 10.1007/s00467-007-0481-7. View

13.

Klaus G, Watson A, Edefonti A, Fischbach M, Ronnholm K, Schaefer F . Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol. 2005; 21(2):151-9. PMC: 1766475. DOI: 10.1007/s00467-005-2082-7. View

14.

McKenna M, Freaney R . Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int. 1999; 8 Suppl 2:S3-6. DOI: 10.1007/pl00022725. View

15.

Langman C, Brooks E . Renal osteodystrophy in children: a systemic disease associated with cardiovascular manifestations. Growth Horm IGF Res. 2006; 16 Suppl A:S79-83. DOI: 10.1016/j.ghir.2006.03.003. View

16.

Tangpricha V, Pearce E, Chen T, Holick M . Vitamin D insufficiency among free-living healthy young adults. Am J Med. 2002; 112(8):659-62. PMC: 3091001. DOI: 10.1016/s0002-9343(02)01091-4. View

17.

Gonzalez E, Sachdeva A, Oliver D, Martin K . Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol. 2004; 24(5):503-10. DOI: 10.1159/000081023. View

18.

Hogg R, Furth S, Lemley K, Portman R, Schwartz G, Coresh J . National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics. 2003; 111(6 Pt 1):1416-21. DOI: 10.1542/peds.111.6.1416. View

19.

Khan S . Vitamin D deficiency and secondary hyperparathyroidism among patients with chronic kidney disease. Am J Med Sci. 2007; 333(4):201-7. DOI: 10.1097/MAJ.0b013e31803bb129. View

20.

Zadshir A, Tareen N, Pan D, Norris K, Martins D . The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis. 2005; 15(4 Suppl 5):S5-97-101. View